NEW YORK, NY / ACCESSWIRE / July 26, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.
Heron Therapeutics, Inc. (NASDAQ: HRTX)
Class Period: October 31, 2018 to April 30, 2019
Lead Plaintiff Deadline: August 5, 2019
Heron Therapeutics, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) Heron had failed to include adequate Chemistry, Manufacturing, and Controls (“CMC”) and non-clinical information in its NDA for HTX-011; (ii) the foregoing increased the likelihood that the FDA would not approve Heron’s NDA for HTX-011; and (iii) as a result, Heron’s public statements were materially false and misleading at all relevant times.
Learn about your recoverable losses in HRTX: http://www.kleinstocklaw.com/pslra-1/heron-therapeutics-inc-loss-submission-form?id=2625&from=1
Ascena Retail Group, Inc. (NASDAQGS: ASNA)
Class Period: September 16, 2015 to June 8, 2017
Lead Plaintiff Deadline: August 6, 2019
Throughout the class period, Ascena Retail Group, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (a) the ANN Acquisition was a complete disaster for the Company as Ann’s operations were in far worse condition than had been represented to the public; (b) in order to mask the true condition of Ann, Defendants improperly delayed recognizing an impairment charge to the value of Ann’s goodwill and, as a result, Ascena’s reported income and assets were materially overstated and the Company’s financial results were not prepared in conformity with GAAP; (c) many of the brands acquired in the ANN Acquisition were in steep decline and were also materially overvalued on Ascena’s Class Period financial statements; and (d) as a result of the foregoing, Defendants lacked a reasonable basis for their positive statements about the Company, its operations and prospects.
Learn about your recoverable losses in ASNA: http://www.kleinstocklaw.com/pslra-1/ascena-retail-group-inc-loss-submission-form?id=2625&from=1
Fred's, Inc. (NASDAQGS: FRED)
Class Period: December 20, 2016 to June 28, 2017
Lead Plaintiff Deadline: August 27, 2019
According to the filed complaint, defendants made numerous materially false and misleading statements concerning the level of regulatory risk faced by the Original Merger and the Revised Merger which would ultimately cause the termination of the Fred’s Asset Purchase Agreement. Specifically, Defendants made false and/or misleading statements: (i) downplaying or disputing contrary reports from journalists signaling regulatory turbulence in closing the merger; (ii) representing that inside knowledge of the FTC gave confidence that the deal would close.
Learn about your recoverable losses in FRED: http://www.kleinstocklaw.com/pslra-1/freds-inc-loss-submission-form?id=2625&from=1
Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.
J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
[email protected]
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com
SOURCE: The Klein Law Firm